OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Jonathan Kocarnik, Kelly Compton, Frances Dean, et al.
JAMA Oncology (2021) Vol. 8, Iss. 3, pp. 420-420
Open Access | Times Cited: 1261

Showing 26-50 of 1261 citing articles:

N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
Xinyue Zhang, Tianhong Su, Yifan Wu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 827-840
Closed Access | Times Cited: 27

Health effects associated with exposure to secondhand smoke: a Burden of Proof study
Luísa Sório Flor, Jason A Anderson, Noah Ahmad, et al.
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 149-167
Open Access | Times Cited: 26

Advances in Understanding the Interplay between Dietary Practices, Body Composition, and Sports Performance in Athletes
Alexandra Martín-Rodríguez, Pedro Belinchón-deMiguel, Alejandro Rubio-Zarapuz, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 571-571
Open Access | Times Cited: 22

Modulating the catalytic activities of nanozymes for molecular sensing
Iman Zare, Daeeun Choi, Jinyi Zhang, et al.
Nano Today (2024) Vol. 56, pp. 102276-102276
Closed Access | Times Cited: 22

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer
Shi-Yang Li, Jan A. Hammarlund, Gang Wu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 7
Open Access | Times Cited: 18

Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 26-34
Closed Access | Times Cited: 18

Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Jeffrey J. Tosoian, Yuping Zhang, Lanbo Xiao, et al.
JAMA Oncology (2024) Vol. 10, Iss. 6, pp. 726-726
Open Access | Times Cited: 16

Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
Rajesh Sharma, Hedayat Abbastabar, Deldar Morad Abdulah, et al.
The Lancet Regional Health - Southeast Asia (2024) Vol. 21, pp. 100333-100333
Open Access | Times Cited: 14

MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 2

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis
Jiaming Liang, Meifeng Chen, Guohong Yan, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Trends in age and antithrombotic therapy in patients who underwent transurethral resection of bladder tumor and perioperative complications
Naoki Wada, Tsubasa Hatakeyama, Haruka Takagi, et al.
International Journal of Urology (2025)
Closed Access | Times Cited: 1

“Cell dedifferentiation” versus “evolutionary reversal” theories of cancer: The direct contest of transcriptomic features
Alexander E. Vinogradov, Olga V. Anatskaya
International Journal of Cancer (2025)
Closed Access | Times Cited: 1

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
Zhichao Li, Haibo Xu, Lei Yu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 59

Body fatness associations with cancer: evidence from recent epidemiological studies and future directions
Susanna C. Larsson, Nikolaos Spyrou, Christos S. Mantzoros
Metabolism (2022) Vol. 137, pp. 155326-155326
Open Access | Times Cited: 49

The Global Incidence, Mortality, and Burden of Breast Cancer in 2019: Correlation With Smoking, Drinking, and Drug Use
Leila Allahqoli, Afrooz Mazidimoradi, Zohre Momenimovahed, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48

Global, regional and national burden, incidence, and mortality of cervical cancer
Zohre Momenimovahed, Afrooz Mazidimoradi, Parang Maroofi, et al.
Cancer Reports (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 45

Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4818-4818
Open Access | Times Cited: 43

The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy
Adele Chimento, Arianna De Luca, Maria D’Amico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1680-1680
Open Access | Times Cited: 38

Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
Alireza Mafi, Malihe Rezaee, Neda Hedayati, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 38

Anticarcinogenic potentials of tea catechins
Xiaoxiang Li, Chang Liu, Shuling Dong, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 37

The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer
Hailun Xie, Guo‐Tian Ruan, Lishuang Wei, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 2, pp. 869-878
Open Access | Times Cited: 36

Scroll to top